Activation of spinal Extacellular Signal‐Regulated Kinases and c‐jun N‐terminal kinase signaling pathways contributes to morphine‐induced acute and chronic hyperalgesia in mice
- 23 April 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (9) , 15045-15056
Abstract
Background: This study investigated the activation of mitogen‐activated protein kinases in the spinal dorsal horn to explore the mechanisms underlying morphine‐induced acute and chronic hyperalgesia in mice.Methods: Male adult mice were given a single subcutaneous injection (SC) of morphine (1 μg/kg) or twice‐daily administration of morphine (10 mg/kg/day) for 8 days. Thermal hyperalgesia and mechanical allodynia were assessed using the radiant heat and von Frey filament test. Levels of phospho (p)‐extracellular signal–regulated kinases (p‐ERK), p‐c‐Jun N‐terminal kinase (p‐JNK), p‐p38, p‐PKCγ, N‐methyl‐d‐aspartate receptor (NMDAr), and c‐Fos protein in the spinal dorsal horn were examined by Western blot assays.Results: A single ultra‐low dose or repeated administration of morphine induced hyperalgesia in mice and caused a significant increase in the levels of p‐ERK and p‐JNK, but not p‐p38, in the spinal dorsal horn. The level of c‐Fos protein was significantly elevated following administration of morphine. The protein levels of p‐PKCγ and NMDAr subunits (NR2B and NR2A) were also altered. Pretreatment with the NMDAr antagonist MK‐801 or the protein kinase C (PKC) inhibitor calphostin C (CC) suppressed the morphine‐induced increase in p‐ERK, p‐JNK, and c‐Fos. Administration of MK‐801 and CC also relieved morphine‐induced hyperalgesia.Conclusion: These findings suggest that activation of the spinal ERK and JNK signaling pathways contribute to morphine‐induced acute and chronic hyperalgesia in mice.Keywords
This publication has 36 references indexed in Scilit:
- Activation of JNK pathway in spinal astrocytes contributes to acute ultra–low-dose morphine thermal hyperalgesiaPain, 2015
- Microglia: A Promising Target for Treating Neuropathic and Postoperative Pain, and Morphine ToleranceJournal of the Formosan Medical Association, 2011
- Opioid-Induced Hyperalgesia and ToleranceAmerican Journal of Therapeutics, 2010
- Low‐dose morphine induces hyperalgesia through activation of Gαs, protein kinase C, and l‐type Ca2+ channels in ratsJournal of Neuroscience Research, 2007
- An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor FunctionThe Scientific World Journal, 2007
- Signaling pathway of morphine induced acute thermal hyperalgesia in micePain, 2006
- Glia: novel counter-regulators of opioid analgesiaTrends in Neurosciences, 2005
- The ERK/MAPK pathway, as a target for the treatment of neuropathic painExpert Opinion on Therapeutic Targets, 2005
- MAPK activation in nociceptive neurons and pain hypersensitivityLife Sciences, 2004
- Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered μ-opioid receptor agonist in the mouseEuropean Journal of Pharmacology, 1995